Search Results 421-430 of 16421 for monoclonal antibody

1. Select thyroid clinical trials at Mayo Clinic

   ... monoclonal antibody with the goal of decreasing TSH receptor antibody levels by 70% to 80%. Enrolled patients will be evaluated jointly by Mayo Clinic ...

2. Ixazomib Citrate, Lenalidomide, Dexamethasone, and Daratumumab in Treating Patients With Newly Diagnosed Multiple Myeloma - Mayo Clinic

   Monoclonal antibodies, such as daratumumab, may block cancer growth in different ways by targeting certain cells. Giving ixazomib citrate, lenalidomide ...

3. Clinical trials - Oncology (Medical)

   ... monoclonal antibody, and compare them with clinical outcomes. A Study of the Impact of the Terminology Used to Identify Papillary Thyroid Cancer on the ...

4. Recurrent Cancer Clinical Trials - Mayo Clinic Research

   Monoclonal antibodies, such as pembrolizumab, may interfere with the ability of tumor cells to grow and spread. Epacadostat may stop the growth of tumor ...

5. A Study to Evaluate Gemcitabine and MK-3475 (Pembrolizumab) to Treat Patients with BCG-Unresponsive Non-Muscle Invasive Bladder Cancer - Mayo Clinic

   Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the patient's immune system attack the cancer, and may interfere with the ability ...

6. Infliximab-dyyb (intravenous route, subcutaneous route) - Mayo Clinic

   This medicine is a monoclonal antibody that works on the immune system. This medicine is available only with your doctor's prescription. This product is ...

7. Adinarayana Kunamneni, Ph.D. - Mayo Clinic Faculty Profiles

   Kunamneni develops multiple technology platforms to discover new single-chain variable fragment and monoclonal antibodies. ... antibody humanization and antibody ...

8. Neoadjuvant Combination Targeted and Immunotherapy for Patients With High-Risk Stage III Melanoma - Mayo Clinic

   Monoclonal antibodies, such as atezolizumab, may interfere with the ability of tumor cells to grow and spread. Giving vemurafenib, cobimetinib, and ...

9. Mayo Clinic expert offers perspective on experimental Alzheimer's disease drug

   A monoclonal antibody, lecanemab shows promise in removing amyloid plaques from the brain. Plaques are one of the defining features of Alzheimer's disease ...

10. Mayo Clinic Uses New Approach to Reverse Multiple Sclerosis in Mice Models

    The monoclonal antibodies used in earlier research are large and complex, but were shown to promote both cell signaling and remyelination of central nervous ...